Background: Enicostemma axillare (Lam.) Raynal is used in traditional practice for the treatment of diabetes, malaria and liver disorders. No systematic toxicity study was described for this plant and hence the present was undertaken to evaluate acute and sub-acute toxicity of aqueous extract of Enicostemma axillare (AEEA). Objective: The acute oral toxicity study of AEEA was carried out as per the OECD guidelines 423 in mice and the sub-acute toxicity was carried out as per the guidelines set by OECD 407 in male and female rats. Materials and Methods: Body weight, food and water consumption, hematological parameters, biochemical parameters, organ weight and histopathological analysis were carried out. Results: No gross toxicity and mortality was observed upto a dose of 2000 mg/kg. For sub-acute toxicity test, 200 mg/kg and 400 mg/kg daily dose of AEEA administered orally for 28 days in male and female group of rats not exhibited any signs of toxicity and mortality.
INTRODUCTION
Enicostemma axillare (Lam.) Raynal (EA) also called as Vellarugu in Tamil and Chotachirayata in Hindi is an important group of medicinal plant belonging to the Gentianaceae family. EA ( Figure 1 ) is a glabrous perennial rainy season herb, growing on moist, damp and shady ridges and slopes of the borders of cultivated fields, chiefly near the sea and often on black cotton soil. 1 Whole plant of EA was reported for the presence of phenols, tannins, flavonoids, glycosides, anthraquinones and sterols. 2 The decoctions of the leaves of EA are used in rheumatism, abdominal ulcers, diabetes, cold swelling, antipyretic, and cough and for stomachache. 3 Anti-diabetic effect of the aqueous extract of EA on streptozotocin induced diabetes mellitus in rats was reported. [4] [5] [6] Antidiabetic efficacy on alloxan induced diabetes mellitus in rats for the extracts of EA was reported. [7] [8] [9] [10] Swertiamarin was isolated from EA 11 and screened for antioxidant and hepatoprotective effect of compound against D-galactosamine induced acute liver damage in rats. Hepatoprotective effect of EA was reported on carbon tetrachloride induced hepatic damage in rats. [12] [13] Hypolipidaemic and antioxidant effect of aqueous extract of EA was reported in cholesterol fed rats.
14 Aerial parts of EA was reported to possess hypolipidaemic effect in p-dimethyl aminobenzene (PDAB) induced hepatotoxic animals. 15 In India, Enicostemma axillare is used by the traditional healers for the treatment of liver disorders, which we have scientifically validated in our earlier study in rats. 16 To ascertain and establish the safety for its use in traditional practice, acute and sub-acute toxicity studies of the aqueous extract of Enicostemma axillare were carried out as per OCED guidelines. 
MATERIALS AND METHODS

Plant materials
Preparation of extracts
Whole plant of Enicostemma axillare was cleaned with distilled water to remove earthy matter and residual materials. It was then shade dried at room temperature (32 ± 2 o C) for 10 days, pulverized to coarse powder, passed through a #40 mesh sieve. Then decoction was prepared by boiling 100 g of the ground plant material in 500 mL of distilled water for about 30 min. 
Animals
Female Albino mice (7-8 weeks old, 20-30 g) and Wistar strains of either sex rats (10-12 weeks old, 150-200 g) were obtained from the animal house of Kovai medical center research and educational trust, Coimbatore, India. The animals were kept in polypropylene cages at a temperature of 25 ± 2°C, RH (50 ± 5%), 12 h light and dark cycles. They were fed with standard laboratory animal diet and water ad libitum. Animals were acclimatized to laboratory conditions before the test. Experiments were designed and conducted in accordance with ethical norms approved by Committee for the Purpose of Control and Supervision on Experiments on Animals (CPCSEA) and Institutional Animal Ethical Committee (IAEC)(KMCRET/AICTE/01/2014-15, dt.31/01/2015).
Acute toxicity study
Acute toxicity test was performed according to OECD 17 guideline 423 for testing of chemicals (2001) . Healthy young adult albino nulliparous, nonpregnant female mice weighing about 20-30 g were administered as a single dose (1 ml) orally using oral feeding needle with 5, 50, 300 and 2000 mg/kg of AEEA in distilled water. Animals were observed individually for first 30 min, periodically during the first 24 h, with special attention given during the first 4 h, and daily thereafter, for a total of 14 days to observe toxicity signs like changes in skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems and behavioural pattern. On 15 th day animals were anaesthetized, blood was collected from the animals for haematological and biochemical analysis. Mice were then sacrificed, dissected and the organs lungs, liver, spleen and kidney were carefully collected, weighed, processed and observed under photomicroscope for histopathological examination.
Sub-acute toxicity study
The sub-acute toxicity assessment of AEEA was performed as per OECD Guideline 407. 18 Wistar strain of rats (150-200 g) was divided into six groups, each consisting of six male and six female rats. Male and female Control groups received only distilled water. Two other groups of each male and female were administered with AEEA in distilled water orally using rat oral feeding needles, daily for 28 days at a dose of 200 mg/kg and 400 mg/kg respectively. During the treatment period the body weight of animals were monitored on 0, 7 th , 14 th , 21 st and 28 th day. Food consumption and water intake for all the groups were observed from day 1 to 28 days. On 29 th day, the overnight fasted rats were anaesthetized with diethyl ether inhalation in a jar containing cotton soaked with diethyl ether. Then blood samples were withdrawn from retro-orbital sinus and the collect- A portion of the blood samples were centrifuged at 10000 rpm for 10 min and the separated serum was analyzed for biochemical parameters viz. Cholesterol, triglycerides, VLDL levels SGOT, SGPT, ALP, total bilirubin, total protein, albumin, globulin, urea, uric acid and creatinine. Biochemical investigations were carried out in an auto analyser (Photometer 5010 V5+, Robert Riely, Berlin) using Piramal healthcare limited reagent kit. The animals were sacrificed by cervical dislocation and the organs, heart, liver, spleen, kidneys, stomach, testes and ovary were isolated and weighed processed and observed under photomicroscope for histopathological examination.
Statistical analysis
The results are expressed as the mean ± SEM. The significance of the difference was evaluated by one-way ANOVA followed by Dunnett's test. Data were considered statistically significant if p<0.05.
RESULTS
Acute Toxicity Study
Single oral administration of AEEA at a dose of 5, 50, 300 and 2000 mg/ kg as per OECD guideline 423 for 14 days did not produce any mortality in tested animals ( Table 1) . No observable sign of toxicity was detected during the experimental period.
Sub-acute toxicity study
Daily oral administration of AEEA at a dose of 200 mg/kg and 400 mg/kg elicited no change in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems and behaviour pattern of the animals observed. Absence of tremors, convulsions, salivation, diarrhoea, and sleep also noted ( Table 2 ). Thus in sub-acute toxicity study, 
+ Indicates normal; − Indicates no effect.
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Parameters observed during acute and sub-acute toxicity studies
Body weight
Gain in body weight of mice and rats was observed in acute and sub-acute toxicity study respectively for control group and AEEA administered animals and the results are recorded in Table 3 and 4.
Food and distilled water consumption
Food and distilled water consumption of mice (acute toxicity) and rats (sub-acute toxicity) were continuously monitored, where there is no change in consumption was observed for treated groups and the control group animals ( Figure 2 to Figure 5 ). 
Hematological analysis
The results of hematological investigations (Table 5 and 6) conducted on day 14 th day for acute toxicity study and on 29 th day for sub-acute toxicity study revealed no significant changes in the values of RBC, WBC, Hb, platelet count, PCV, differential count, MPV, MCV, MCH, MCHC and RDW of treated groups when compared with the respective control mice and rats respectively.
Biochemical Investigations
Biochemical investigations were performed in order to review any toxic effects produced after administration of AEEA on liver and kidney. There was no significant alteration in cholesterol triglycerides and VLDL levels in treated groups of sub-acute toxicity study when compared with control group of rats (Table 7) . No significant change observed in (serum glutamic oxaloacetic transaminase) SGOT, (Serum glutamic pyruvic transaminase) SGPT, (alkaline phosphatase) ALP and total bilirubin content of treated group animals when compared with control group animals ( Table 8 and 9 ). There was no significant alteration observed in creatinine, urea and uric acid levels of treated group animals when compared with control group animals ( Table 10 and 11). 
Organ weight
No abnormal change in the relative weight of internal organs of mice and rats was observed when compared to control group as shown in Table  12 and 13.
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Histopathological investigation
Acute toxicity study in mice
Lungs
Normal alveoli with blood vessels and normal bronchioles were observed in histopathological investigation of lungs of control group of animals in both 10 x and 40 x magnifications. Normal alveoli with bronchioles was observed in treated group of animals in both the magnifications ( Figure 6 ).
Liver
Histopathological section of liver in control group and AEEA treated group (2000 mg/kg) showed normal lobular architecture. The central veins, sinusoids are found to be normal in the AEEA treated groups. Toxic signs like inflammation, fatty change or fibrosis were not found ( Figure 7 ).
Sub-acute toxicity study in rats
Heart
Section from the heart of control group and AEEA treated to male and female groups at a dose of 400 mg/kg showed normal myocytes ( Figure  10 and 11 ). 
Spleen
Section from the spleen of control group and EAAE treated group (2000 mg/kg) showed red pulp congestion. No change was observed in white pulp, pencillar artery and the red pulp ( Figure 8 ).
Kidney
Sections from kidney of control group and AEEA treated group (2000 mg/kg) showed normal cortex, medulla and normal glomeruli. The interstitium was found to be normal and no inflammation or necrosis was observed ( Figure 9 ).
Lungs
Normal alveoli and normal bronchioles were observed in control group and AEEA treated to male and female groups at a dose of 400 mg/kg (Figure 12 and 13 ).
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Liver Histopathological section of liver in control group and AEEA treated to male and female groups at a dose of 400 mg/kg showed normal lobular architecture. The portal tracts, hepatocytes, central veins, sinusoids are found to be normal. No evidence of toxic signs observed as there is no inflammation, fatty change or fibrosis (Figure 14 and 15 ). 
Stomach
Section from the stomach of control group and AEEA treated to male and female groups at a dose of 400 mg/kg showed normal mucosa, muscle layer and stomach glands (Figure 16 and 17) .
Spleen
Section from the spleen of control group and AEEA treated to male and female groups at a dose of 400 mg/kg showed normal spleen with red
Kidney
Sections from kidney of control group and AEEA treated to male and female groups at a dose of 400 mg/kg showed normal cortex and medulla. The cortex showed normal glomeruli. The interstitium and distal convoluted tubules are found to be normal. No inflammation or tubular necrosis was observed (Figure 20 and 21 ).
Testes
Sections from kidney of control group and AEEA treated to male groups at a dose of 400 mg/kg showed normal testes and spermatozoa ( Figure 22 ).
Ovary
Sections from kidney of control group and AEEA treated to female groups at a dose of 400 mg/kg showed normal ovarian follicles ( Figure 23 ).
DISCUSSION
Acute and sub-acute studies in mice and rats were performed as per OECD guidelines 423 and 407 respectively to assess the safety profile of AEEA, as there were no earlier reports on the safety assessment of aqueous extract of Enicostemma axillare. In acute toxicity test, mortality was not observed in mice with the maximum dose of 2000 mg/kg throughout the 14 days of study. In sub-acute toxicity test also no mortality was observed in male and female rats with the maximum dose of 400 mg/kg throughout 28 days of study. Significant changes were not found in breathing, sense of touch/sound, central nervous systems, behaviour pattern and locomotor activity. Convulsion, tremor, excessive salivation, diarrhea, sedation and edema were not observed. Body weight and internal organ weight changes is sensitive and indicative marker for the first sign of toxicity when exposed to toxic substances. 19 All animals were found to be active with increase in body weight both in acute and sub-acute toxicity study. Normal food and water consumption of animals clearly support the gain in body of animals throughout the study period. Hematopoietic system is the most sensitive target for toxic substances and it is the important index of physiological and pathological status [20] [21] and hence hematological investigation was carried out. No abnormality was observed in hematopoietic function indices for AEEA treated groups compared with control groups indicating the extract is safe. Lipid profile assessment was performed for the animals treated with AEEA to verify any changes observed in serum levels of triglycerides, cholesterol and VLDL. 22 No significant variation in cholesterol, triglycerides and VLDL levels in AEEA treated groups when compared with control groups. SGOT, SGPT, ALP and bilirubin levels of the experimental animals were monitored as they are the specific markers for liver damage or injury. 23 No significant changes in SGOT, SGPT, ALP and bilirubin level was observed in all the treated group animals. Thus animals treated with AEEA were found to be non-hepatotoxic. To assess whether treatment of AEEA to rats causes any damage to kidney, kidney function test was performed. GLDH-UV Kinetic method, Jaffe method and Uricase POD method was adopted to evaluate the important markers of renal dysfunction viz. urea, uric acid and creatinine levels respectively. 24 AEEA was found to be safe and nontoxic to kidney as there is no significant change observed in creatinine, urea and uric acid levels of AEEA treated group of animals both in acute and sub-acute toxicity when compared with control group animals. When compared with control groups, no variation in relative organ weight was observed for AEEA treated groups both in acute and sub-acute toxicity study. The above mentioned biochemical investigations were in correlation with the histopathological studies. Section of the heart of the control and AEEA treated animals showed no abnormality as shown in Figures 10 and 11 . Alveoli and bronchioles were found to be normal both in control and treated group confirming that AEEA did not cause any toxicity to lungs of the animals. Inflammation or cirrhosis or necrosis was not observed in the histological study of liver in mice and rats tested with AEEA at a dose of 400 mg/kg. Normal cortex, medulla and normal glomeruli were observed indicating that AEEA did not cause any damage to kidney. Cross section of stomach under low and high power magnification showed normal mucosal surface, normal stomach glands and normal lamina propria indicated that AEEA not caused any toxicity to rats. Histological sections of testes clearly implicated that no testicular toxicity was observed to the treated male group of rats for 28 days in sub-acute study. Observation of normal cervix, mucosa and follicles from histological sections of ovary confirmed that AEEA was non toxic to ovary of female rats. 
CONCLUSIONS
Based on our results, we conclude that AEEA were found to be safe up to a dose of 2000 mg/kg/day. Hematological, biochemical and histopathological investigations clearly demonstrates that single oral administration upto 2000 mg/kg in acute toxicity study and daily oral administration of the AEEA for 28 days upto 400 mg/kg in sub-acute toxicity study caused no damage to the organs like heart, lungs, liver, spleen and kidney. Abnormalities were also not observed in the organs stomach, testes and ovary of the animals tested at a dose of 200 and 400 mg/kg respectively. The study provided significant data on the sub-acute toxicity profile of AEEA which may be valuable in the clinical study of medicinal herb Enicostemma axillare. The aqueous extract of Enicostemma axillare thus may be used for manufacturing pharmaceutical formulations.
